About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNANCT04808674

Remediation for Mild Cognitive Deficits After Cancer

Cancer survival rates have improved significantly over the past decades and patients now experience a number of side effects including cancer-related cognitive impairment (CRCI): problems with memory,...

Lead sponsor: Hospices Civils de Lyon•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Sophie JACQUIN-COURTOIS, PhD

CONTACT

04.78.86.50.64 sophie.courtois@chu-lyon.fr

Mélanie COGNÉ, MD

CONTACT

02.99.28.42.18 melanie.cogne@chu-rennes.fr

Sponsors

Lead Sponsor

Hospices Civils de Lyon

Age

18 - 65 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Treated in the past for breast cancer with chemotherapy, surgery, and / or radiotherapy,
•Admitted as a day patient at the Henry Gabrielle Hospital or the Pontchaillou CHU Hospital during the study,
•Given free, informed consent in writing after being informed orally and in writing of the how the study will proceed.

Exclusion Criteria

•Presence of another active cancer,
•Ongoing chemotherapy and/or radiotherapy treatment,
•Active progression of breast cancer,
•History of neurological or psychiatric conditions,
•Major disturbances in comprehension that prevent them giving free, informed consent,
•Pregnant, parturient or breastfeeding women,
•Person under a legal protection measure such as guardianship or curatorship,
•People not affiliated to a social security scheme (French Social Security) or beneficiaries of a similar scheme.

Related studies

RECRUITINGPhase 1

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

NCT06347068 · Breast Cancer, Relapse, and more

RECRUITINGPhase 3

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

NCT06500481 · Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, and more

A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship

NCT07655934 · Breast Cancer

Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors

NCT07436078 · Female Breast Cancer, Prostate Cancer, and more

RECRUITINGPhase 1/2

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

NCT07288359 · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 13, 2023Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment24

Start dateDec 2021

Last updatedJan 13, 2023

Condition

Cognitive Remediation Breast Cancer

Locations shown

Hospices Civils de Lyon - Groupement hospitalier sud - Hôpital Henry Gabrielle - Service de médecine physique et de réadaptation

Lyon

Hôpital Pontchaillou - Service de Médecine Physique et de Réadaptation

Rennes

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 13, 2023Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions